1. Home
  2. SSM vs VBIO Comparison

SSM vs VBIO Comparison

Compare SSM & VBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono Group N.V. Ordinary Shares

SSM

Sono Group N.V. Ordinary Shares

N/A

Current Price

$0.73

Market Cap

1.5M

Sector

N/A

ML Signal

N/A

Logo Valion Bio Inc. Common Stock

VBIO

Valion Bio Inc. Common Stock

N/A

Current Price

$0.51

Market Cap

1.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SSM
VBIO
Founded
2016
2016
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5M
1.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
SSM
VBIO
Price
$0.73
$0.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
64.6K
★ 248.6K
Earning Date
11-10-2026
12-01-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $780,000.00
Revenue This Year
$1,418,080.40
N/A
Revenue Next Year
$48.46
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.65
$0.12
52 Week High
$10.54
$812.50

Technical Indicators

Market Signals
Indicator
SSM
VBIO
Relative Strength Index (RSI) 31.53 22.39
Support Level N/A $0.47
Resistance Level $4.35 $4.39
Average True Range (ATR) 0.11 0.05
MACD 0.01 0.60
Stochastic Oscillator 18.90 27.92

Price Performance

Historical Comparison
SSM
VBIO

About SSM Sono Group N.V. Ordinary Shares

Sono Group NV is engaged in the field of solar-powered electric mobility. With its proprietary solar technology, the company is able to integrate solar panels into a vehicle's bodywork, using energy captured from the sun to charge the vehicle's battery. The group is engaged in the design and development of its own first solar electric vehicle, the Sion. Its Products and services include Complete Solar Solutions, Solar Charge Controllers, Solar Modules, Data Services, and Engineering Services. The company's single business segment manages the financing, research and development, and product commercialization.

About VBIO Valion Bio Inc. Common Stock

Valion Bio Inc is a late-stage biopharmaceutical company developing biologics that activate innate immune pathways for cytoprotection and immune modulation. Its main candidate, Entolimod, is a TLR5 agonist and also advances Entolasta, a next-generation TLR5 agonist, and targets the neutropenia oncology supportive care market.

Share on Social Networks: